Startups
impact 16
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
Why it matters
This signals a broader shift in aidesigned. The real question is whether drugs moves the needle for practitioners.